A number of national and international organizations are advocating more intensive screening for Chlamydia trachomatis and Neisseria gonorrhoeae in high-prevalence populations as a way to reduce the prevalence of these infections. In this article, we review the available evidence and conclude that there is a paucity of evidence to support this approach. We further hypothesize that increasing screening intensity in high-prevalence populations will result in a considerable risk for the emergence of antimicrobial resistance in Neisseria gonorrhoeae and other pathobionts.

Originele taal-2Engels
TijdschriftJournal of Medical Microbiology
Pagina's (van-tot)132-135
Aantal pagina's4
StatusGepubliceerd - 2018

ID: 2789466